Complete Program

Click here to view all Congress Abstracts.

Click here to download the full Scientific Program for the TTS Congress (7 August, pdf, 69kb)

Click here to see a list of all ePosters presented at the TTS Congress (7 August, pdf)

Sunday, 15 August 2010
08:30 - 13:15 Canadian Transplant Academy (CTA) Training Day with TTS Post Graduate Course
 
13:30 - 17:30 Astellas Satellite Symposium
 
18:00 - 19:00 Opening Ceremony, Ballroom A/B, Level 1
19:00 - 20:30 Welcome Reception, Hall A, Exhibition Level

 

Monday, 16 August 2010
07:00 - 08:15 Sunrise Symposia
SUN01:ROTRF Symposium: Antibody-Mediated Rejection - an Ounce of Prevention is Worth a Pound of Cure
SUN02: Improving Outcomes in kidney transplantation: Non-HLA Antibodies and Enhanced Clinical Risk Assessment (Absorber Symposium)
SUN03: Optimal Screening of Donors and Recipients
SUN04: Formation, Detection and Characterization of Antibodies to Transplantation Antigens
SUN05: The Art of Patient Care
 
08:30 - 10:00 Plenary I
Lecture 1 • Basic Science: Vision and Future of Systems Biology
Lecture 2 • Translational: Beyond the Genome
Lecture 3 • Clinical: Monitoring Allograft Status in the 21st Century: A Noninvasive Molecular
 
10:00 – 10:30 Coffee Break
 
10:30 - 12:00 Morning Concurrent Symposia/Oral Sessions 
O01: Experimental Immunobiology
O02: T Cell Diversity and Functional Biology
O03: Genomics and Biomarkers
O04: Organ Donation and Allocation I
O05: Induction Immunosuppression
O06: CMV Infection
O07: A New Century of Pediatric Transplantation?
O08: Immunosuppression for Liver Transplantation
O09: Optimizing Immediate Graft Function in Kidney Transplantation
O10: Mesenchymal Stem Cells and Cellular Transplantation
O11: Late Breaking
 
12:00 - 13:30 Pfizer Lunch Symposium
 
12:15 - 13:15 Mini Oral Sessions 
MO01: Immune Regulation and Tolerance I
MO02: Clinical and Ethical Aspects of Living Donor Transplantation
MO03: Induction Immunosuppression
MO04: Epidemiology and Clinical Outcomes
MO05: Living Liver Donors and Techniques
MO06: Laboratory Immunology and Kidney Transplantation
MO07: Islet and Pancreas Transplantation I
 
13:30 - 15:00 State of the Art Symposia 
SOTA 01: Global Strategies to Improve Deceased Organ Donation
SOTA 02: Hematopoietic Stem Cell Transplantation
SOTA 03: Induction Immunosuppression
SOTA 04: Allorecognition and Response
SOTA 05: Antibody-Mediated Rejection (AMR). The Changing Face of Rejection in Heart Transplantation
SOTA 06: Living Donor Liver Transplantation
SOTA 07: Islet Transplantation: Immunology and Physiology
 
15:00 – 15:30 Coffee Break
 
15:30 - 17:00 Afternoon Concurrent Symposia/Oral Sessions
O12: Experimental Ischemia and Reperfusion Injury
O13: Assays to Predict Allorgraft Rejection
O14: Molecular Mechanisms of Delayed Kidney Graft Function
O15: Access to Treatment and Quality of Life
O16: Use of mTor inhibitors and MPA I
O17: Non-Viral Infections in Transplantation
O18: Biologic and Therapeutic Advances in Heart Transplantation I
O19: The Problem of Viral Hepatitis in Liver Transplantation
O20: Options and Outcomes in the Sensitized Kidney Recipient
O21: Clinical Islet Transplantation
 
17:30 - 18:30 Genzyme Satellite Sympsium
 

 

Tuesday 17 August 2010
07:00 - 08:15 Sunrise Symposia
SUN06: ELPAT: Altruistic Organ Donation to a Stranger
SUN07: Genetically Modified Pigs For Xenotransplantation
SUN08: What's New in Transplant ID
SUN09: "How Can We Reduce the 30 Day Mortality After Heart Transplantation?"
SUN10: Proteomics in Transplantation - A BC Proteomics Network Symposium
SUN11: The Road to Tolerance (One Lambda Symposium)
 
08:30 - 10:00 Plenary II
Lecture 1 • Basic Science: Why is the Alloresponse so strong?
Lecture 2 • Translational: Inducing Transplantation Tolerance
Lecture 3 • Clinical: Tolerance in Clinical Transplantation
 
10:00 – 10:30 Coffee Break
 
10:30 - 12:00 Morning Concurrent Symposia/Oral Sessions
O22: B Cells and Antibody Responses
O23: Activation and Role of T Regulatory Cells
O24: Molecular Mechanisms of Chronic Kidney Graft Injury
O25: Organ Donation and Allocation II
O26: New Immunosuppressive Agents
O27: BK Virus Infection
O28: Innovations in Composite Tissue Transplantation
O29: Outcomes of Liver Transplantation I
O30: Therapeutic Strategies for Kidney transplantation
O31: Cell Therapy and Stem Cells
O32: Late Breaking
 
12:00 - 13:30 Novartis Lunch Symposium
 
12:15 - 13:15 Mini Oral Sessions
MO08: Immune Regulation and Tolerance II
MO09: International Trends in Organ Donation
MO10: New Immunosuppressive agents
MO11: Societal Issues and public policy
MO12: Immunuosuppression in Liver Transplantation
MO13: Clinical Strategies and Outcomes in Kidney Transplantation
MO14: Islet and Pancreas Transplantation II
 
13:30 - 15:00 State of the Art Symposia 
SOTA 08: Principles and Practice of Living Donor Exchange
SOTA 09: Biology and Therapeutic Potential of Regulatory Cells
SOTA 10: Maintenance Immunosuppression
SOTA 11: Transplant Genomics and Biomarkers of Injury
SOTA 12: Biological Function and Clinical Relevance of Antibodies to Transplantation Antigens
SOTA 13: Liver Transplantation For Hepatocellular Cancer
SOTA 14: Islet Cell Replacement: Outcomes and Allocation
 
15:00 – 15:30 Coffee Break
 
15:30 - 17:00 Afternoon Concurrent Symposia/Oral Sessions 
O33: Cellular Mechanisms of Immune Regulation
O34: Cellular Assays of the Graft Response
O35: Biomarkers in Kidney Transplantation
O36: Ethics, Public Policy and Economics
O37: Use of mTor inhibitors and MPA II
O38: Malignancy After Transplantation
O39: Biologic and Therapeutic Advances in Heart Transplantation II
O40: HCC and Living Donor Transplantation
O41: Transplantation in ABO mismatched and sensitized recipients
O42: Clinical Pancreas Transplantation I
 
17:30 - 18:30 Bristol-Myers Squibb Satellite Sympsium
 

 

Wednesday, 18 August 2010
07:00 - 08:15 Sunrise Symposia
SUN12:

TTS/IPTA Symposium on Pediatric Transplantation: Overcoming Barriers to Successful Organ Transplantation in Children
SUN13: Xenotransplantation: From the Lab to the Clinic
SUN14: Complications of Transplantation
SUN15: Detection and Monitoring of Antibodies Prior to Transplantation
SUN16: The Biology of Patient Care
 
08:30 - 10:00 Plenary III
Lecture 1 • Basic Science: Generation, Programming and Applications of Induced Pluripotent Stem Cells
Lecture 2 • Translational: Advances in Regenerative Biology and Organ Biogenesis
Lecture 3 • Clinical: Lung Repair, Regeneration and Transplantation
 
10:15 – 12:00  The President’s Plenary
 
12:00 - 13:30 Astellas Transplant Lunch Symposium
 
12:15 - 13:15 Mini Oral Sessions
MO15: Immunological monitoring
MO16: Organ Donation, Preservation and Allocation
MO17: CNI Minimization Strategies
MO18: Innovations in Heart Transplantation I
MO19: Interventions and Outcomes in Liver Transplantation I
MO20: Xenotransplantation
MO21: Late Breaking
 
13:30 -15:00 State of the Art Symposia 
SOTA 15: Developing Societal and Ethical Consensus on Living Donation
SOTA 16: Innovations in Regenerative Medicine
SOTA 17: Prevention and Treatment of Antibody Mediated Rejection
SOTA 18: Immune Regulation and Tolerance
SOTA 19: Clinically Relevant Molecular Mechanisms in Lung Transplantation
SOTA 20: Hepatitis C Positive Patient
SOTA 21: Ischemia - Reperfusion Injury
 
15:00 – 15:30 Coffee Break
 
15:30 - 17:00 Afternoon Concurrent Symposia/Oral Sessions
O43: Experimental and Human Tolerance
O44: Xenotransplantation I
O45: Molecular Diagnostics and Genomics
O46: Epidemiology and Clinical Outcomes II
O47: Clinical Trials of Immunosuppression
O48: Advances in Surgery and Imaging
O49: Molecular and Clinical Aspects of Lung Transplantation
O50: Intestine and Multivisceral Transplantation
O51: Immunological Monitoring in Kidney Transplantation
O52: Experimental Islet Transplantation
 
17:30 - 19:00 Novartis Satellite Symposium
 

 

Thursday 19 August 2010
07:00 - 08:15 Sunrise Symposia
SUN17: Women in Transplantation
SUN18: IATDMCT Partner Symposium: Therapeutic Monitoring of Immunosuppression
SUN19: Exciting Updates in CMV
SUN20: Detection and Monitoring of Antibodies after Transplantation
08:30 - 10:00: Plenary 4
Lecture 1 • Basic Science: miRNA in Immunity and Transplantation
Lecture 2 • Translational: Guidance of Immunosuppression by Biomarkers
Lecture 3 • Clinical: Current Advances in Clinical Immunosuppression
10:00 – 10:30 Coffee Break
10:30 - 12:00 Morning Concurrent Symposia/Oral Sessions 
O53: Clinical Role of HLA Antibodies
O54: NK Cells in Graft Injury and Acceptance
O55: Molecular and Cellular Pathology of the Kidney Allograft
O56: Epidemiology and Clinical Outcomes I
O57: Pre-clinical immunosuppressive agents
O58: Other Viral Infections in Transplantation
O59: Striving to Harness the Immune System in Pediatric Solid Organ Transplantation
O60: Outcomes of Liver Transplantation II
O61: Bone Marrow Transplantation
O62: Clinical Pancreas Transplantation II
O63: Xenotransplantation II
 
12:00 - 13:30 Roche Lunch Symposium
12:15 - 13:15 Mini Oral Sessions 
MO22: Immunopharmacology
MO23: Pediatric Organ Transplantation
MO24: Cardiac and Metabolic Complication of Transplantation
MO25: Innovations in Heart Transplantation II
MO26: Interventions and Outcomes in Liver Transplantation II
MO27: Experimental and Clinical Lung Transplantation
MO28: Stem Cells and Cellular Transplantation
13:30 - 15:00 State of the Art Symposia 
SOTA 22: Planning for Donation After Cardiac Death
SOTA 23: Tissue Transplantation and Reconstruction
SOTA 24: Immunosuppression and Post-Transplant Malignancy
SOTA 25: Injury, Repair and Remodeling
SOTA 26: Cellular Xenotransplantation
SOTA 27: Graft Injury in Liver Transplantation
SOTA 28: Intestinal Transplantation
 
15:00 - 16:00 Closing Ceremony
 

 

Please continue to visit the website for the most up to date information and
Join the Mailing List to receive important announcements regarding the Congress.